Skip to Content
Merck

A4326

Arylamine acetyltransferase from pigeon liver

lyophilized powder, ~0.5 units/mg protein

Synonym(s):

NAT

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
EC Number:
UNSPSC Code:
12352204
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

pigeon liver

form

lyophilized powder

specific activity

~0.5 units/mg protein

composition

Protein, ~10% biuret

shipped in

dry ice

storage temp.

−20°C

Physical form

Contains sucrose as a stabilizer.

Other Notes

One unit will acetylate 1.0 nanomole of p-nitroaniline per min at pH 8.0 at 25 °C.


Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Edith Sim et al.
Advances in pharmacology (San Diego, Calif.), 63, 169-205 (2012-07-11)
Arylamine N-acetyltransferases (NATs) are defined as xenobiotic metabolizing enzymes, adding an acetyl group from acetyl coenzyme A (CoA) to arylamines and arylhydrazines. NATs are found in organisms from bacteria and fungi to vertebrates. Several isoenzymes, often polymorphic, may be present
Mariola Rychlik-Sych et al.
Przeglad lekarski, 69(3), 120-124 (2012-07-07)
The etiology of dermatological diseases is still unknown. Involvement of genetic and environmental factors in the pathogenesis of dermatological diseases has contributed to a number of studies whose aim is to elucidate the way in which xenobiotics exert effects on
Francisco Jose Forestiero et al.
Clinica chimica acta; international journal of clinical chemistry, 415, 215-219 (2012-10-27)
The relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver biomarkers was investigated in individuals under anti-tuberculosis drug therapy. Tuberculosis outpatients (18-70 y) with (n=59) and without (n=40) mild increase of liver enzymes (MILE) at two-month treatment